Search clinical trials for: Amiloride hydrochlorothiazide

Total 454 results

EMS

Withdrawn

Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control

Essential Arterial Hypertension
Takeda

Completed

Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension

Essential Hypertension

Netherlands, Austria, Germany, Poland, United Kingdom
Oregon Health and Science University
Oregon Clinical and Translational Research Institute

Completed

A Translational Approach to Gitelman Syndrome

Gitelman Syndrome

United States
Novartis

Completed

Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension (AIMS)

Hypertension

United States
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers

Essential Hypertension
Cedars-Sinai Medical Center
Merck Sharp & Dohme LLC

Withdrawn

Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes. (Ertugliflozin)

Hypertension | Diabetes Mellitus, Type 2

United States
Novartis Pharmaceuticals

Completed

ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling (ALLMARK)

Hypertension | Left Ventricle Hypertrophy

Spain
Takeda

Completed

Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension

Essential Hypertension

United States, Chile, Mexico
Takeda

Completed

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.

Essential Hypertension

United States, Canada
Takeda

Completed

One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

Hypertension

United States, Chile, Mexico
Novartis

Completed

Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients

Hypertension

Taiwan
Reprieve Cardiovascular, Inc

Not yet recruiting

EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System (FASTR-EU) (FASTR-EU)

Acute Decompensated Heart Failure

Netherlands, Poland
Wilhelminenspital Vienna
Association for the Promotion of Research in Atherosclerosis, Thrombosis... and other collaborators

Completed

Lowering Blood Pressure in Primary Care in Vienna (Low BP Vienna)

Hypertension

Austria
University Hospital Tuebingen

Terminated

Amiloride in Nephrotic Syndrome (AMILOR)

Edema | Nephrotic Syndrome | Sodium Retention

Germany
University of Southern Denmark
Odense University Hospital; The Ministry of Science, Technology and Innovation... and other collaborators

Unknown

Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease

Hypertension | Diabetic Nephropathies

Denmark
Universität des Saarlandes

Completed

Study to Evaluate the Influence of Hydrochlorothiazide on Dermal Photosensitivity and DNA Stability - a Pilot Study (HCTox Study)

Photosensitivity

Germany
Boryung Pharmaceutical Co., Ltd
Seoul National University Hospital

Completed

A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide

Hypertension

Korea, Republic of
Hotel Dieu de France Hospital

Unknown

Fixed-Free HTN Trial

Hypertension

Lebanon
Shanghai WiseGain Medical Devices Co., Ltd.

Unknown

Randomized Controlled Trial of Renal Denervation for Resistant Hypertension

Hypertension

China
West China Hospital

Unknown

Treatment of Hypertension in Tibetan Adult Population

Hypertension

China
Norwegian University of Science and Technology
St. Olavs Hospital; Alesund Hospital; Namsos Hospital; Volvat Medisinsk Senter...

Recruiting

Bariatric Surgery and Pharmacokinetics of Hydrochlorothiazide

Obesity, Morbid

Norway
Massachusetts General Hospital

Recruiting

Diffusion MRI in Heart Failure

Myocardial Infarction | Heart Failure | Left Ventricular Hypertrophy

United States
West China Hospital

Completed

Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency

Hypertension | Renal Insufficiency

China
Centre Hospitalier Universitaire Vaudois

Completed

Effect of Aliskiren and Hydrochlorothiazide on Kidney Oxygenation in Patients With Hypertension

Hypertension

Switzerland
Eli Lilly and Company

Completed

A Study in People With Mild Hypertension

Mild Hypertension

Sweden
University of California, San Francisco

Completed

Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers (CKD)

Kidney Disease

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg and Lopressor HCT® Tablets 100/50 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Metoprolol Tartrate/Hydrochlorothiazide Tablets 100/50 mg to Lopressor HCT® Tablets 100/50 mg

Healthy

United States
Vanderbilt University Medical Center

Completed

Aldosterone and the Metabolic Syndrome

Glucose Metabolism Disorders | Metabolic Diseases | Diabetes Mellitus | Endocrine System Diseases

United States
Novartis

Completed

Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II Hypertension (ACADEMY)

Stage II Hypertension

Thailand
Novartis

Completed

VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women

Hypertension

Switzerland, Germany
Novartis

Completed

Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients

Hypertension

Germany, Switzerland
Daiichi Sankyo, Inc.
Integrium

Completed

A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure (BP CRUSH)

Hypertension

United States
Boehringer Ingelheim

Completed

Add-on to Micamlo BP Trial

Hypertension

Japan
Yokohama City University Medical Center

Completed

Kanagawa Combination Anti-hypertensive Therapy (K-CAT)

Hypertension

Japan
Sankyo Pharma Gmbh

Completed

Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension (OLMETREAT)

Essential Hypertension

France, Austria, Switzerland, Belgium, Germany, Italy, Netherlands, United Kingdom, Portugal
Daiichi Sankyo, Inc.

Completed

Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension (Benibest)

Essential Hypertension
Novartis

Terminated

Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH)

Hypertension

United States, Denmark, Finland, Norway, Sweden
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaborators

Completed

Action to Control Cardiovascular Risk in Diabetes (ACCORD) (ACCORD)

Cardiovascular Diseases | Coronary Disease | Hypertension | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Atherosclerosis | Hypercholesterolemia

United States, Canada
Tulane University School of Medicine

Completed

Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus (UFLC)

Hypertension | Type 2 Diabetes

United States
Creighton University
Dialysis Clinic, Inc.

Unknown

Chlorthalidone and HCTZ Impacts on Platelet Activation

Hypertension

United States
Bristol-Myers Squibb

Completed

A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs

HIV Infections

United States
Daiichi Sankyo, Inc.

Completed

Vascular Improvement With Olmesartan Medoxomil Study (VIOS)

Hypertension

United States
LaborMed Pharma S.A.

Completed

A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM (AISHA)

Hypertension | Type 2 Diabetes Mellitus

Romania
Novartis

Completed

Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population (ACTION)

Hypertension

United States
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Mechanisms of Diuretic Resistance in Heart Failure, Aim 2 (MsDR 2)

Heart Failure

United States
Torrent Pharmaceuticals Limited

Completed

Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.

Healthy Subjects
Organon and Co

Completed

HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)

Hypertension | Type 2 Diabetes Mellitus
Pharmtechnology LLC
Altasciences Company, Inc.

Unknown

A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions

Bioequivalence

Canada
Columbia University

Completed

N-of-1 Trials for Blood Pressure Medications in Adults

Hypertension | High Blood Pressure

United States

3

Subscribe